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We previously reported an association between high bonemass (HBM) and a bone-forming phenotype of radio-
graphic hip osteoarthritis (OA). As knee and hipOAhave distinct risk factors, in this studywe aimed to determine
(i) whether HBM is also associated with knee OA, and (ii) whether the HBM knee OA phenotype demonstrates a
similar pattern of radiographic features to that observed at the hip.
HBM cases (deﬁned by DXA BMD Z-scores) from the UK-based HBM study were compared with unaffected
family controls and general population controls from the Chingford and Hertfordshire cohort studies. A single
blinded observer graded AP weight-bearing knee radiographs for features of OA (Kellgren–Lawrence score,
osteophytes, joint space narrowing (JSN), sclerosis) using an atlas. Analyses used logistic regression, adjusting
a priori for age and gender, and additionally for BMI as a potential mediator of the HBM–OA association, using
Stata v12.
609 HBM knees in 311 cases (mean age 60.8 years, 74% female) and 1937 control knees in 991 controls
(63.4 years, 81% female) were analysed. The prevalence of radiographic knee OA, deﬁned as Kellgren–Lawrence
grade ≥ 2, was increased in cases (31.5% vs. 20.9%), with age and gender adjusted OR [95% CI] 2.38 [1.81, 3.14],
p b 0.001. The association between HBM and osteophytosis was stronger than that for JSN, both before and
after adjustment for BMI which attenuated the ORs for knee OA and osteophytes in cases vs. controls by approx-
imately 50%.
Our ﬁndings support a positive association between HBM and knee OA. This association was strongest for
osteophytes, suggesting HBM confers a general predisposition to a subtype of OA characterised by increased
bone formation.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
Introduction
The nature of the relationship between bone mineral density
(BMD) and osteoarthritis (OA) remains a topic of debate [1]. While
epidemiological studies have consistently demonstrated an associa-
tion between higher BMD and both prevalent [2–5] and incident
[6–8] radiographic OA of the large joints, the mechanisms behind
these associations remain unclear; understanding these mechanisms
will be key to translating research ﬁndings into therapeutic beneﬁt
[1]. To address this question from a novel perspective, we set out to
investigate the prevalence and phenotype of OA in our cohort of
high bone mass (HBM) individuals [9], compared with a control
group. HBM individuals have extreme elevations in BMD likely to
be genetically determined [9,10] and thus present from early adult-
hood, constituting a unique population for the investigation of causal
pathways between BMD and OA. We have recently shown that HBM
is associated with both an increased prevalence of self-reported joint
replacement [11], and an increased prevalence of radiographic hip
OA with a predominance of bone-forming features (osteophytosis
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and subchondral sclerosis) [12]. HBM is also associated with other
characteristics which may potentially contribute to a higher risk of
OA, including increased body mass index (BMI) [13].
While hip and knee OA both increase with age [14], evidence sug-
gests that OA at these two joint sites has different determinants [15].
In particular, whereas local mechanical factors acting at the joint
level may be more important for hip OA [16], knee OA has a stronger
association with OA at other joint sites such as the hand [14,17] sug-
gesting a more generalised systemic predisposition to the disease.
The concept of knee and hip OA as different diseases is supported
by the fact that hip OA appears to be more heritable than knee OA
[18], and genetic studies indicate little genetic correlation between
the two disorders [19]. The role of speciﬁc risk factors for OA at
these two joint sites is also thought to differ; for example, the rela-
tionship between obesity and OA is reported to be stronger at the
knee compared with the hip [15,20,21], and knee OA is more preva-
lent in females than males [14]. We therefore wished to establish
whether any relationship between HBM and OA of the knee is similar
to that previously observed at the hip.
The aim of this study was to investigate radiographic knee OA in
our HBM population, determining i) whether HBM is associated
with an increased prevalence of radiographic knee OA, ii) the pheno-
type of knee OA in HBM compared with controls in terms of individ-
ual radiographic features, and iii) the role of potential mediators
such as BMI.We hypothesized that, in line with our previous ﬁndings
and evidence from general population studies, HBMwould be associ-
ated with a bone-forming phenotype of radiographic knee OA.
Methods
The HBM population
HBM cases were recruited as part of the UK-based HBM study,
a multi-centre observational study of adults with unexplained
HBM. Index cases were initially identiﬁed by screening DXA data-
bases for T and/or Z-scores ≥ +4. All DXA images were inspected
by trained clinicians in order to exclude scans with artefactual
elevation of DXA BMD, resulting in 49.4% of scans being excluded
due to degenerative disease/osteoarthritis/scoliosis, and a further
15.5% for other reasons including surgical/malignant/Pagetic
artefacts etc. Then, in order to identify generalised HBM, the HBM
index case deﬁnition was reﬁned to either a) L1 Z-score ≥ +3.2
plus total hip Z-score ≥ +1.2 or b) total hip Z-score ≥ +3.2 plus
L1 Z-score ≥ +1.2. A +3.2 threshold was consistent with the only
published precedent for identifying HBM using DXA [22]. L1 Z-score
was used to avoid misclassifying individuals with lower lumbar OA
as having HBM [9,23]. Z rather than T-score limited age bias.
Further HBM cases were identiﬁed through DXA assessment of the
relatives and spouses of index cases. In ﬁrst-degree relatives, HBM
was deﬁned as a summed L1 Z-score plus total hip Z-score ≥ +3.2.
41% of relatives screened were affected and combined with HBM
index cases, with remaining unaffected ﬁrst-degree relatives/
spouses forming a family control group. Full details of this DXA data-
base screening and recruitment have been previously reported [9].
Assessments, including a structured interview and clinical examina-
tion, were identical in both HBM cases and controls, and AP weight-
bearing knee X-rays were performed in all participants according to
local protocols at each centre. Recruitment ran from July 2005–April
2010. Written informed consent was obtained from all participants
in line with the Declaration of Helsinki [24] and the study was
approved by the Bath multi-centre Research Ethics Committee
(REC) and each NHS local REC. For this study, HBM cases were then
categorised into 5-year age bands by gender, prior to selection of ad-
ditional population controls, using age and gender-stratiﬁed random
sampling.
Population-based controls
Population controls were selected from the Chingford 1000-
women study (ChS) and Hertfordshire cohort study (HCS). The ChS
is a prospective longitudinal female population-based cohort which
initially recruited 1003 women aged 45–64 from the age/sex register
of a general practice in Chingford, North-East London [2]; 20-year
follow-up has recently taken place. AP knee radiographs were
obtained in years 1, 5, 10, 15 and 20. Controls, according to age at
the time of X-ray, were randomly sampled in a 2:1 ratio with HBM
female cases for each age band apart from the lower (40–50 years)
and upper (N80) bands (3:1). A single radiograph per participant
was included in our study, with controls in the upper age bands
selected ﬁrst to ensure sufﬁcient numbers of available ﬁlms.
The HCS [25] recruited approximately 3000 men and women
born in Hertfordshire between 1931 and 1939 and still resident
there in 1998–2003. Recently a subset of HCS participants were
recruited into the European Project on Osteoarthritis (EPOSA) [26];
these individuals (207 men and 203 women now aged between
71.5 years and 80.6 years) had AP pelvis +/− weight-bearing knee
X-rays performed during 2011. These individuals were randomly
sampled 2:1 with HBM cases within each appropriate age band
(70–75, 75–80 and N80).
Assessment of radiographs
All available case and control radiographswere pooled for assessment.
Files were automatically relabelled with anonymised codes, and present-
ed in a randomorder to ensure blinding of the assessor. Radiographswere
graded by a single observer (SH) following focussed radiological training.
X-ray images were viewed and quantitative measurements made using
open source ImageJ software [27]; semi-quantitative assessments were
recorded within a Microsoft Access database.
Each knee was ﬁrst assigned a global Kellgren–Lawrence OA grade
[28], followed by semi-quantitative grading of individual radiographic
features of OA using an established atlas [29] (Table 1); the presence
or absence of chondrocalcinosis (previously shown to be associated
with radiographic knee OA and osteophytosis [30]) was also noted
(0–1). Each of these features was recorded separately in the medial
and lateral compartments. For knees with OA (KL grade ≥ 2) only, the
compartments affected (medial/lateral/both) were recorded. As all
radiographs were performed AP, only the tibiofemoral joint was
assessed.
A Kellgren–Lawrence grade of 2 (at least 1 deﬁnite osteophyte)
deﬁned the presence of OA in the main analysis; however, because
Table 1
Semi-quantitative scoring of radiographic features of knee osteoarthritis. Grading of indi-
vidual radiographic features (except chondrocalcinosis) was performed using an atlas
[29]. KL (Kellgren–Lawrence) grades deﬁned as 0— no features of OA, 1— doubtful osteo-
phyte, 2 — deﬁnite osteophyte, 3 — deﬁnite osteophyte plus narrowing, 4 — osteophyte/
narrowing/deformity as in Spector 1993 [34]. OA = osteoarthritis, OP = osteophyte,
JSN = joint space narrowing.
OA feature Categorical
grading
Binary
variable (s)
KL grade (global knee OA) 0–4 KL grade ≥ 2 (OA present),
KL grade ≥ 3 (moderate OA)
Medial compartment osteophyte 0–3 Any osteophyte
(any OP grade ≥ 1),
moderate osteophyte
(any OP grade ≥ 2)
Lateral compartment osteophyte 0–3
Medial JSN 0–3 Any JSN (JSN grade ≥ 1),
moderate JSN
(JSN grade ≥ 2)
Lateral JSN 0–3
Medial sclerosis 0–1 Subchondral sclerosis
(grade ≥ 1)Lateral sclerosis 0–1
Medial chondrocalcinosis 0–1 Chondrocalcinosis
(grade ≥ 1)Lateral chondrocalcinosis 0–1
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deﬁnitions of knee OA vary between studies [31], results are also
shown using a KL grade threshold of ≥3 (osteophytes and joint
space narrowing). Categorical scores for the individual radiographic
features were converted to binary variables for analysis (Table 1).
Quantitative measurement of minimum medial compartment joint
space width (JSW) was made within Image J, using the line tool,
facilitated by a simple macro. JSW measurement was limited to the
medial compartment only, as this measure is poorly reproducible
in the lateral compartment of the knee [32–34]. As differences in
radiographic protocols between studies can potentially result in
varying degrees of magniﬁcation of the X-ray image, we could not
reliably compare quantitative measures between studies; analysis
of measured JSW was therefore limited to the HBM cases and family
controls only.
Image quality was rated by the operator at the time of assessment
(good, poor, very poor), with very poor X-rays, judged in terms of
penetration and/or resolution, excluded. If the X-ray was grossly
rotated or tilted, this was recorded. Joint replacements were record-
ed and these knees excluded from the main analysis (a sensitivity
analysis was later performed including these X-rays). At the end of
the study 126 randomly selected knees were re-graded by the
primary observer to assess intra-rater repeatability. Intra-rater
kappa values for the above listed binary variables were all ≥0.78
except subchondral sclerosis (0.39); however, subchondral sclerosis
was rarely seen. The intra-rater kappa for knee compartment
involvement (medial/lateral/both) was 0.84. The intra-class
correlation coefﬁcient (ICC) for minimum measured JSW was 0.98.
Assessment of covariates
Values for age, gender and body mass index (BMI) were obtained
from each pre-existing study dataset. Age was deﬁned by the time of
X-ray. BMI was calculated as weight (kg)/height (metres2) using
the closest available weight and height measurements to the time of
the X-ray. Body composition data, derived from total body DXA scans,
were available in a proportion of HBM cases and family controls
using methods previously described [13]. As total body DXA scans in
the HBM group were performed on both GE Lunar Prodigy and Hologic
Discovery DXA scanners depending on recruitment centre, validated
cross-calibration equations were applied for all bone and soft tissue
regions of interest [35]. Additional height, weight and BMI measures
obtained at the time of total body DXAwere also available in this group.
Statistical analysis
Demographic statistics for the HBM cases and each control popula-
tion were summarised as mean (SD) for continuous variables and
counts (percentages) for categorical variables. In this case–control
analysis, categorical variables were initially cross-tabulated and
percentages calculated: the chi-squared (χ2) test was used to assess
the association between binary variables, and the unpaired t-test to
compare mean values for continuous JSW. Associations between HBM
case status and binary radiographic OA outcomes were then analysed
using generalised estimating equations (GEE) with a logistic link
function (logistic regression allowing for clustering of observations
within individuals, i.e. right/left knees). Analyses were adjusted for the
a priori confounders age and gender, and then additionally for BMI as
a potential mediator. Odds ratios before and after adjustment are
presented with 95% conﬁdence intervals (95% CI), and p values from
Wald signiﬁcance tests. GEE using an identity link function (linear
regression allowing for clustering) was used to compare medial
compartment minimum JSW (mm) in HBM cases and family controls,
adjusting for confounders. The possible mediating role of BMI was
then more formally explored using a binary mediation approach with
a probit model, and additionally by adjusting for the different compo-
nents of body mass (fat mass, lean mass etc.) in turn. Analyses were
repeated stratiﬁed by gender.
Pre-planned sensitivity analyses comprised: i) exclusion of poor
quality/rotated/tilted X-rays, ii) a “person-level” analysis of the
worst knee in each individual, iii) adding radiographic knee
(A) (B) (C)
3838 Chingford female control 
visits within sampling frame
219 controls selected
403 knees analysed
209 controls selected 
with X-ray available
410 HCS EPOSA participants 
with X-ray date 
1172 knees analysed
184 family controls 
with ≥1 knee X-ray 
available
201 family controls
366 knees
362 knees analysed
13 knee 
replacements
358 HBM cases
623 knees
313 HBM cases with 
≥1 knee X-ray 
available
1 excluded: 
unacceptable quality 
(0.16%)
609 knees analysed
17 no knee X-ray 
performed2
45 no knee X-ray 
performed1 627 controls selected
10 no knee X-
ray available4
17 no knee X-
ray available3
610 controls selected with X-ray 
available (240 year 1, 23 year 5, 168 
year 10, 4 year 15, 175 year 20)
408 knees1207 knees
2 knee replacements, 3 
knees incomplete data
4 knee replacements 13 knee replacements, 2 
knees incomplete data
0 excluded: 
unacceptable quality
0 excluded: 
unacceptable quality 
20 excluded: 
unacceptable quality 
(1.7%)
Fig. 1. Flowdiagram summarising selection of radiographs for inclusion in the study. (A) Selection of highbonemass (HBM) case and family control X-rays (process of recruitment to study
described previously). (B) Selection of Chingford study female control X-rays. (C) Selection of HCS EPOSA male and female control X-rays. 1Reason recorded for missing X-rays in HBM
cases: unable to travel (n = 7), no X-rays at study centre (n = 10), unable to attend/wait/comply (n = 3), patient declined (n= 6), reside abroad (n= 2), bilateral knee replacements
(n=6), not done (reason unknown) (n=10). 2Reason recorded formissingX-ray in family controls: unable to travel (n=1), did not continue in study (n=1), noX-rays at study centre
(n= 4), unable to attend/wait/comply (n= 3), patient declined (n=2), bilateral knee replacements (n= 3), reason unknown (n= 3). 3Reason recorded for missing X-ray in Chingford
controls: did not continue in study (n = 3), ﬁle corrupted (n= 2), unknown (n = 12). 4Reason recorded for missing X-ray in HCS EPOSA controls: bilateral knee replacements (n = 6),
unknown (n = 4).
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replacements to the dataset, assuming these were performed for OA,
iv) excluding HBM cases/controls with self-reported inﬂammatory
arthritis, and v) restricting the analysis to those HBM cases meeting
the index case deﬁnition at the hip. Data were analysed using Stata
release 12 statistical software (StataCorp, College Station, TX, USA).
Results
Participant selection and characteristics
Fig. 1 summarises the selection of radiographs for inclusion in our
study. 21 knee joints (n = 1 case, 20 controls) were excluded from
the outset due to unacceptable image quality. Knee replacements
were also excluded (n = 13 cases, 19 controls). 2546 knees from 1302
individuals were included in the primary combined analysis comprising
609 HBM case knees, 362 family control knees, 1172 ChS control knees
and 403 HCS control knees. 1244 individuals contributed two knees to
the analysis and 58 individuals contributed only one knee. Table 2 sum-
marises the demographics of the study population. HBM cases were
slightly younger than the combined controls (mean 60.8 years vs.
63.4 years), with a lower proportion of females (74.3% vs. 81.3%). As ex-
pected, HBM cases had substantially higher values for standardised
BMD at both the hip and lumbar spine compared with controls. Mean
BMI was also greater in cases than controls (30.6 vs. 27.3 kg/m2).
HBM case status and knee OA: unadjusted analyses
The prevalence of the different OA outcomes is shown for HBM
cases, each separate control group, and all control groups combined
(Table 3). The prevalence of radiographic knee OA (deﬁned as KL
grade≥ 2) was 31.5% in HBM cases and 20.9% in the combined controls
(p b 0.001); as expected this was identical to the prevalence of any os-
teophyte (≥grade 1). Moderate osteophytes (≥grade 2), moderate JSN
(≥grade 2) and chondrocalcinosis were also more prevalent in HBM
cases. No difference was observed between the HBM cases and the
combined control group in the prevalence of milder JSN (≥grade 1) or
subchondral sclerosis (which was only seen infrequently). Knee OA
deﬁned as KL grade ≥ 3 was also more prevalent in HBM cases.
HBM case status and knee OA: analyses adjusted for age and gender
Following age and gender adjustment, radiographic knee OA
remained strongly associated with HBM, with an odds ratio [95% CI] of
2.38 [1.81,3.14], p b 0.001 (model 2, Table 4). Of the individual radio-
graphicOA features, the largest odds ratioswere seen for the osteophyte
variables (e.g. OR 2.40 [1.69,3.41] for moderate osteophyte, p b 0.001).
The odds of any JSN did not differ between cases and controls (1.18
[0.86,1.62], p = 0.299); however, moderate JSN remained more
Table 2
Demographics of study population. N for all variables is as shown except where indicated. HBM = high bone mass, ChS = Chingford 1000-women study, HCS = Hertfordshire cohort
study, SD = standard deviation, BMI = body mass index, BMD = bone mineral density, L1–L4 = 1st to 4th lumbar vertebrae. BMD variables standardised according to scanner type
(Hologic for Chingford/HCS controls, mixed Lunar/Hologic for HBM cases and family controls) using standard equations [54,55].
HBM cases (N = 311) Family controls (N = 183) ChS controls (N = 599) HCS controls (N = 209) Combined controls (N = 991)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age (years) 60.8 (14.3) 54.0 (16.1) 62.1 (10.0) 75.2 (2.61) 63.4 (12.5)
BMI (kg/m2) 30.6 (5.83) 28.0 (4.77) 27.0 (4.79) 27.7 (4.34) 27.3 (4.71)
BMD total hip (g/cm2) 1.27a (0.19) 1.00c (0.14) 0.91e (0.13) 0.97 (0.14) 0.94g (0.14)
BMD L1–L4 (g/cm2) 1.55b (0.19) 1.18d (0.17) 1.04f (0.17) 1.10 (0.20) 1.08h (0.18)
N (%) N (%) N (%) N (%) N (%)
Females 231 (74.3) 85 (46.5) 599 (100) 122 (58.4) 806 (81.3)
a N = 300.
b N = 299.
c N = 180.
d N = 181.
e N = 519.
f N = 583.
g N = 908.
h N = 973.
Table 3
Prevalence of knee OA features in HBM cases and control groups. P values refer to comparison with HBM cases. N for all variables is as shown except where indicated and refers to
number of knee joints analysed. Quantitative measure of joint space width (JSW) limited to HBM study participants (HBM cases and family controls) only. p values from chi-squared test
(binary outcomes)/unpaired t-test (continuous minimum JSW). ChS = Chingford 1000-women study, HCS = Hertfordshire cohort study, SD = standard deviation.
HBM cases
(N = 609)
Family controls
(N = 362)
ChS controls
(N = 1172)
HCS controls
(N = 403)
Combined controls
(N = 1937)
N (%) N (%) p N (%) p N (%) p N (%) p
Knee OA (KL ≥ 2) 192 (31.5) 46 (12.7) b0.001 234 (20.0) b0.001 124 (30.8) 0.799 404 (20.9) b0.001
Knee OA (KL ≥ 3) 81 (13.3) 22 (6.1) b0.001 87 (7.4) b0.001 64 (15.9) 0.251 173 (8.9) 0.002
Any osteophyte (≥grade 1) 192 (31.5) 46 (12.7) b0.001 235 (20.1) b0.001 124 (30.8) 0.799 405 (20.9) b0.001
Osteophyte (≥grade 2) 86 (14.1) 12 (3.3) b0.001 93 (7.9) b0.001 51 (12.7) 0.504 156 (8.1) b0.001
Any JSN (≥grade 1) 91 (14.9) 37 (10.2) 0.035 149 (12.7) 0.191 95 (23.6) 0.001 281 (14.5) 0.791
JSN (≥grade 2) 36 (5.9) 8 (2.2) 0.007 32 (2.7) 0.001 31 (7.7) 0.265 71 (3.7) 0.016
Subchondral sclerosis 18 (3.0) 6 (1.7) 0.208 28 (2.4) 0.475 8 (2.0) 0.339 42 (2.2) 0.264
Chondrocalcinosis 53 (8.7) 17 (4.7) 0.020 50 (4.3) b0.001 53 (13.2) 0.024 120 (6.2) 0.032
Mean (SD) Mean (SD) p Mean (SD) p Mean (SD) p Mean (SD) p
Minimum JSW (medial), mma 4.35 (1.18) 4.62 (1.09) 0.001 – – – – – –
a N = 607 (HBM cases), 360 (family controls)
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frequent in the HBM group (1.95 [1.20,3.18], p = 0.007). The odds of
chondrocalcinosis (1.65 [1.02,2.66], p = 0.042) was also greater in the
HBM group, but did not explain the association between HBM and
knee OA (OR 2.33 [1.77,3.09] for knee OA (KL≥ 2) in HBM cases vs. con-
trols after adjustment for the presence of chondrocalcinosis). More
severe knee OA (KL ≥ 3) was also associated with HBM case status
(1.98 [1.39,2.82], p b 0.001), albeit with a slightly smaller odds ratio
than that seen with our primary deﬁnition.
These analyses were repeated comparing HBM cases with each of
the separate control groups, and then stratiﬁed by gender. Adjusted
ﬁndings were broadly similar when analyses were restricted to HBM
cases vs. family controls (Supplementary Table 1). Minimummeasured
JSW in the medial compartment did not differ between the HBM cases
and family controls (mean difference 0.02 mm [−0.15,0.20],
p = 0.817, adjusted for age and gender). Comparing HBM female
cases with ChS controls alone (Supplementary Table 2), and older
HBM cases with HCS controls (Supplementary Table 3) also gave broad-
ly similar results. When restricted to females only (Supplementary
Table 4), estimates for most variables were essentially unchanged
with respect to the main analysis. In males (Supplementary Table 5),
odds ratios for several outcomes in HBM cases increased, including
knee OA, osteophytes, JSN and subchondral sclerosis. However,
conﬁdence intervals were widened, reﬂecting the smaller numbers of
males included in our study, and no formal evidence of a gender
interaction was seen (interaction p value 0.53 for KL ≥ 2, with
age adjustment).
Effect of adjusting for BMI
Further adjustment for BMI resulted in partial attenuation of the age
and gender adjusted odds ratios for moderate osteophytes and knee OA
in HBM cases vs. controls (Fig. 2). The association between HBM case
status and knee OA deﬁned as KL≥ 3was fully attenuated (Supplemen-
tary Table 6). These results suggest that BMI is a partial mediator of the
HBM–OA association at the knee. Mediation analysis was used to
explore this possibility further. By comparing the coefﬁcients for the
direct and indirect (via BMI) pathways, it was estimated that 45% of
the association between HBM case status and knee OA is mediated by
BMI (Fig. 3).
Total body DXA data were available in 190 HBM cases (mean age
61 years, 75.8% female) and 121 family controls (mean age 55 years,
46.3% female). We used these data to explore the effect of adjusting
for different body mass compartments on the HBM–OA relationship
(Supplementary Table 7). Using our age and gender adjusted model,
adjustment for height and then either weight, or fat and leanmass, pro-
duced similar degrees of attenuation compared with BMI adjustment.
When each parameter was added individually to the regression
model, fat mass resulted in the greatest attenuation of the HBM–OA
association (similar to that for BMI) whereas lean mass, despite
representing a greater proportion of overall mass, appeared less impor-
tant. If anything, adjustment for individual fat compartments (trunk,
peripheral [arms and legs], android and gynoid) led to less attenuation
than adjustment for total fat mass, suggesting that overall weight and
fat mass are more important than fat distribution.
Pattern of knee OA in HBM cases vs. controls
Patterns of knee compartment involvement were examined ﬁrst in
all knees with KL grade≥ 2, and then in knees with KL≥ 3 (deﬁnite os-
teophyte plus narrowing) only (Table 4), excluding those HBM cases
with a self-reported history of inﬂammatory arthritis. Predominantme-
dial compartment disease was the most prevalent pattern in both HBM
cases and controls, in whom OA patterns were similar. If anything,
amongst narrowed knees, the proportion of medial compartment dis-
ease was slightly greater in HBM cases compared with the control
group (p = 0.037); however, this association did not persist after age
and gender adjustment.
Sensitivity analyses
315X-rays (15 HBM case knees, 300 control knees)were considered
to be poor quality in terms of resolution/penetration/artefact etc. A fur-
ther 210 knees (58 case knees, 152 control knees) had signiﬁcant rota-
tion or tilt. Excluding all of these knees from the analysis did not
materially affect the HBM–knee OA association observed (OR 2.45
[1.82,3.30], p b 0.001 for KL ≥ 2, adjusted for age and gender). Findings
for JSN (most likely to be affected by tilt) were also essentially un-
changed (data not shown). A person-level analysis, in which the worst
knee per participant was analysed, also gave similar results (Supple-
mentary Table 8). Radiographic knee replacements were excluded
from the main analysis; including these knees (n = 32) and grading
them as KL = 4 resulted in marginally increased odds ratios for knee
OA in HBM (Supplementary Table 9). A small number of HBM cases
and family controls reported a history of inﬂammatory arthritis: exclud-
ing these knees from the overall combined analysis (n = 35 HBM case
knees, 4 family control knees) again did not materially change our
ﬁndings (OR 2.33 [1.76,3.09], p b 0.001 for KL ≥ 2, adjusted for age
and gender). Data on inﬂammatory arthritis were not available for theTable 4
GEE regression analysis of radiographic knee OA variables in HBM cases vs. all combined
controls. Results show odds ratios (OR), with 95% conﬁdence interval (95% CI). N (total
no. of knee joints analysed) = 609 HBM cases, 1937 controls. Model 1 = unadjusted,
model 2 = adjusted for age and gender. GEE = generalised estimating equations with
logistic link function.
Outcome Model OR (95% CI) in
HBM cases vs. controls
p value
Knee OA (KL ≥ 2) 1 1.76 (1.37, 2.27) b0.001
2 2.38 (1.81, 3.14) b0.001
Knee OA (KL ≥ 3) 1 1.59 (1.14, 2.22) 0.006
2 1.98 (1.39, 2.82) b0.001
Any osteophyte (≥grade 1) 1 1.76 (1.37, 2.26) b0.001
2 2.38 (1.80, 3.13) b0.001
Osteophyte (≥grade 2) 1 1.89 (1.35, 2.64) b0.001
2 2.40 (1.69, 3.41) b0.001
Any JSN (≥grade 1) 1 1.05 (0.78, 1.43) 0.731
2 1.18 (0.86, 1.62) 0.299
JSN (≥grade 2) 1 1.71 (1.06, 2.75) 0.027
2 1.95 (1.20, 3.18) 0.007
Subchondral sclerosis 1 1.42 (0.76, 2.63) 0.270
2 1.66 (0.89, 3.11) 0.112
Chondrocalcinosis 1 1.42 (0.92, 2.20) 0.111
2 1.65 (1.02, 2.66) 0.042
Table 5
Pattern of knee OA, summarised according to HBM case status, in combined population.
Top panel shows compartment involvement in all knees with OA (deﬁned as KL ≥ 2; at
least one deﬁnite osteophyte) n = 169 HBM case knees, 390 control knees. Bottom panel
shows compartment involvement in knees with KL ≥ 3 (osteophyte plus narrowing),
n = 75 HBM case knees, 166 control knees. Knees of HBM cases/family controls with
self-reported inﬂammatory arthritis (n = 12), and knees with appearances suggesting
secondary OA (n = 2) excluded. Note that a small number of knees with KL grade ≥ 2
were missing the knee compartments variable (n = 23).
Compartment affected Medial Lateral Both p valuea
N (%) N (%) N (%)
Knees with KL grade ≥ 2
HBM cases 103 (61.0) 31 (18.3) 35 (20.7) 0.467
Controls 220 (56.4) 89 (22.8) 81 (20.8)
All 323 (57.8) 120 (21.5) 116 (20.8)
Knees with KL grade ≥ 3 (i.e. knees with narrowing)
HBM cases 65 (86.7) 4 (5.3) 6 (8.0) 0.037
Controls 120 (72.3) 26 (15.7) 20 (12.1)
All 185 (76.8) 30 (12.5) 26 (10.8)
a p values from chi-squared test.
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population controls. Restricting the analysis to those HBM cases
meeting our index deﬁnition on the basis of their hip BMD alone
(total hip Z-score ≥ +3.2, n = 268 knees) resulted in an increased
age and gender-adjusted OR for knee OA (OR 3.19 [2.21, 4.62],
p b 0.001 for KL ≥ 2 in HBM cases vs. controls).
Discussion
Our data indicate an increased prevalence of radiographic knee OA
in HBM individuals compared with controls, consistent with existing
epidemiological evidence that increased BMD is a risk factor for OA at
this joint [2,5,6,8,36]. As we hypothesized, associations with HBM
were stronger for the osteophyte variables compared with both semi-
quantitative and measured JSN, particularly in models adjusted for
BMI, and the stronger association we observed between HBM and
kneeOAdeﬁned as KL≥ 2 (osteophytosis) versus KL≥ 3 (osteophytosis
plus JSN) is likely to be a further reﬂection of this. However, we found
little evidence of an association between HBM and subchondral sclero-
sis, possibly explained by the very low prevalence of this feature and/or
the difﬁculty of assessing its presence or absence on simple visual in-
spection of radiographs. A positive association between HBM and
chondrocalcinosis was also seen; however, while chondrocalcinosis
was also associated with radiographic knee OA, it did not explain the
HBM–OA association observed.
Adjusting for BMI attenuated the HBM–knee OA association by
approximately 50%, suggesting that the HBM–OA association at the
knee is partly mediated through increased BMI.We previously reported
that HBM is associated with a metabolic phenotype comprising greater
BMI [9], and increased fat mass in women [13]; similar body composi-
tion changes have been observed in association with OA [37,38].
The primary mechanism by which weight/BMI contributes to OA in
load-bearing joints has not been fully established; in particular the
relative contribution of increased joint loading due to greater body
weight [14,15] versus the effects of circulating metabolic factors such
as adipokines [39] remains to be determined. It is interesting that, in
our total body DXA analyses, adjusting for fat mass led to greater atten-
uation of the HBM–OA association compared with lean mass
adjustment. This is consistent with some previous studies suggesting
that increased fat mass relative to leanmass may be particularly associ-
atedwith OA at the knee [40,41], possibly indicating a role formetabolic
factors over and above body weight in determining OA risk. There may
be gender differences in these relationships, for example a recent study
Fig. 2. Effect of BMI adjustment on association between HBM case status and osteophyte/knee OA. OR= odds ratio in HBM cases vs. combined controls; error bars show 95% conﬁdence
interval. Model 1 = unadjusted, model 2 = adjusted for age and gender, model 3 = adjusted for age, gender and BMI. N (total no. knee joints analysed) = 2546 (609 HBM cases, 1937
controls). Dashed line shows OR of 1 (ie. no difference between the groups).
Indirect eﬀect (via BMI): coeﬀ = 0.23 [0.18, 0.28]
Increased BMI
HBM Knee OA (KL ≥2)
Direct eﬀect (age and gender adjusted): coeﬀ = 0.29 [0.14, 0.42]
Fig. 3.Mediation analysis examining direct and indirect association of HBM with radio-
graphic knee OA (probit model). Knee OA deﬁned as KL grade ≥ 2. N = 609 HBM cases,
1937 controls. Coefﬁcient for total effect of HBM on knee OA (probit model) = 0.52
[0.37, 0.65]. Indirect effect (dashed arrow) represents the proportion of the effect estimat-
ed to bemediated by BMI. Ratio of indirect:direct effect estimated as 0.81, with proportion
of total effectmediated by BMI 0.45 (45%). Estimates and 95% conﬁdence intervals [square
brackets] were obtained using a non-parametric bootstrap procedure with resampling for
1000 iterations. Conﬁdence intervals are based on 2.5th and 97.5th percentiles of the
bootstrapped distribution.
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suggested that fatmass and leanmassmay bemore important determi-
nants of knee OA inwomen andmen respectively [42]; this observation
may therefore reﬂect the greater proportion of women in our study.
Unfortunately numbers of males with total body DXA data did not
permit gender-stratiﬁed analysis. It should be noted that these analyses
were restricted to a subgroup of HBM cases and family controls only,
resulting in limited statistical power.
We previously reported, based on a study of this same population,
that HBM is associatedwith a bone-forming (osteophyte-predominant)
phenotype of hip OA [11]. Unlike in the present study, adjusting for BMI
resulted in only minimal attenuation of the association between HBM
and hip OA comparedwith age and gender adjustment alone, consistent
with evidence that BMI is less strongly associated with hip than knee
OA. However interestingly, following age, gender and BMI adjustment,
overall odds ratios for OA in HBM cases vs. combined controlswere sim-
ilar at the hip (1.52 [1.09,2.11]) [12] and the knee (1.62 [1.22,2.16]),
suggesting that the increased risk of OA conferred as a direct result of
HBM (independent of BMI) is similar at both joint sites. These ﬁndings
suggest ﬁrstly that increased BMD is an important risk factor for OA at
both the hip and knee, and secondly that increased bone formation, as
evidenced by osteophytosis, drives this association at both joint sites.
Extreme BMD elevation, as seen in our HBM cases, is likely to be
primarily genetically determined. Therefore an important consideration
is the extent to which HBM individuals may be predisposed to
“standard” (previously termed “common garden-variety” [43]) OA, as
opposed to a distinct OA subtype arising from the pleiotropic effects of
rare genetic variants. The former would have greater implications for
our understanding of OA in the general population. We explored this
question by examining the compartmental distribution of knee OA in
our study population; whereas knee OA is expected to predominantly
affect the medial tibiofemoral joint (subject to greater loading [44]),
many rarer inﬂammatory, erosive or genetic forms of OA have a predi-
lection for the lateral compartment [43]. Our observation that predom-
inantly medial compartment knee OA was by far the most common
pattern in both the HBM and control groups supports the view that
HBM is associated with an increased risk of “standard” OA, and that
the mechanisms underlying this relationship are applicable to the
wider population.
Plausible mechanisms that might contribute to a bone-forming phe-
notype in HBM include upregulation of the Wnt signalling pathway.
Activating mutations of this pathway are known to result in HBM [22],
and evidence is accumulating for a role of altered Wnt signalling in OA
[45–47]. Wnt signalling is also known to play a key role in the anabolic
response of bone tomechanical loading, as evidenced by animal studies
[48,49], and blockade of the Wnt signalling pathway inhibitor DKK-1
has been shown to promote osteophytosis in mice [50]. While the
precise genetic basis of HBM in the majority of cases remains to be
determined [51], and is the subject of ongoing studies, it is interesting
to note that a genome-wide association study in this population showed
overrepresentation of SNPs associated with BMD in the wider popula-
tion including loci in Wnt pathway genes [10].
Our study has a number of limitations.We lack temporal data, so the
direction of causality cannot be formally assessed; nevertheless, we as-
sume the onset of genetically determined HBMwould predate the onset
of OA (a disease of later life) in this population. However, it is theoreti-
cally possible that OA features within the DXA ﬁeld (e.g. lumbar
osteophytosis) could lead to artefactual elevation of measured BMD,
with the potential to induce a spurious association between HBM and
OA if spine and knee OA are correlated as part of a “generalised OA”
phenotype. As discussed, every effort wasmade to avoid suchmisclassi-
ﬁcation of HBM status through both inspection of DXA images and our
case deﬁnition; also the fact that the association between HBM and
knee OA remained robust when restricted to those HBM cases with
high hip BMD is reassuring, as hip OA is thought to have only a minimal
inﬂuence on measured hip BMD [52]. Case–control studies are prone to
selection bias; it is possible that less mobile individuals with OA were
less likely to participate (or were selectively lost to follow-up in the
ChS/HCS); however, such bias would be expected to affect both the
HBMand control groups in the same direction. The lack of a standardised
X-ray protocol across all centres may have reduced our sensitivity to de-
tect differences in JSN between groups; this is likely to have particularly
affected measured JSW in the HBM cases and family controls. [13].
Adjusting for BMI measured at a single time-point may have
underestimated its effect on the HBM–OA association, as a previous
study found that peak recalled body weight was superior to current
BMI in predicting radiographic OA [53]. Finally, we cannot exclude resid-
ual confounding by factors such as physical activity which were not
assessed in a consistent format across the different study populations.
In conclusion, our data support an association between HBM and
an increased prevalence of radiographic knee OA predominantly
characterisedbyosteophytosis. Taken togetherwith our previousﬁndings
at the hip joint, this suggests that HBM individuals have a predisposition
to a bone-forming phenotype of OA affecting multiple weight-bearing
joint sites. In addition, BMI appears to be a partial mediator of the
HBM–OA association at the knee, suggesting that HBMmodiﬁes the risk
of knee OA via multiple pathways. Our ﬁndings add to existing evidence
that increased BMD represents a risk factor for OA of the large joints,
and suggest a mechanism involving an altered balance between bone
formation and resorption.
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